Knockdown of HOXA11-AS expression in ovarian cancer cells significantly inhibited the malignant behavior of ovarian cancer cells and increased their sensitivity to cisplatin(P < 0.05). This evidence concerns the gene HOXA11 and ovarian carcinoma.